Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Phosphodiesterase-5 Inhibitors in Neurodegenerative Diseases: A Path to Cognitive Rescue.
Monoallelic POLR3A Variants Cause Early-Onset Peripheral Neuropathy.
Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models.
Data resource profile: PharmaNet, the database for prescription drug dispensing in British Columbia, Canada.
Cerebrospinal Fluid Metabolites and Brain Imaging in Epilepsy Subtypes: Mendelian Randomization and Multi-Omics Analysis.
Integrative Perspectives on COX-2 Signaling and Selective Inhibitors in Central Nervous System Disorders: A Narrative Review.
Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison.
Procyanidins and Bifidobacterium infantis alleviate anxiety and depression-like behavior in alcohol use disorder withdrawal mice via the gut-immune-brain axis.
Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras.
SMART-MC: Characterizing the Dynamics of Multiple Sclerosis Therapy Transitions Using a Covariate-Based Markov Model.
Early immune events during SARS-CoV-2 infection impact memory T and B cell responses.
Efficacy and Safety of Cannabis Derivates and Their Synthetic Analogs. Overview of Systematic Reviews.
Comments on: Iron accumulation in the corpus callosum; a quantitative MRI study in relapsing-remitting multiple sclerosis.
Atypical Presentation of Rapidly Progressive Guillain-Barré Syndrome With Dysautonomia in an Adolescent With Persistent Infection: A Case Report.
Susceptibility Source Separation Unveils Paramagnetic and Diamagnetic Trajectories in Healthy Brains From 5 to 90 Years.
Annexin A1 and its membrane receptor complex: Implications for immune regulation and autoimmune disease mechanisms.
How do people with multiple sclerosis who have walking difficulties perceive participation? A qualitative analysis.
Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy.
A Case of Persistent Ataxia and Atypical Brain Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings.
Social isolation during adolescence alters novel object recognition memory, brain and gut gene expression, and microbiota composition in a sex-specific manner.
Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison.
Difficult relationships between humans and bacteria: associations between multiple sclerosis and the human microbiome.
Epidemiologic, clinical and diagnostic characteristics of late-onset multiple sclerosis compared with adult-onset multiple sclerosis.
Expert Panel Consensus Guidelines of the German Society of Neuroradiology on the Use of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Multiple Sclerosis.
Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination.
Pages
« first
‹ previous
…
975
976
977
978
979
980
981
982
983
…
next ›
last »